microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells
- 8 December 2016
- journal article
- research article
- Published by Springer Nature in Cellular Oncology
- Vol. 40 (2) , 119-131
Abstract
Purpose Previously, it has been reported that microRNA-145 (miR-145) is lowly expressed in human cervical cancers and that its putative tumour suppressive role may be attributed to epithelial-mesenchymal transition (EMT) regulation. Here, we aimed to assess whether miR-145 may affect EMT-associated markers/genes and suppress cervical cancer growth and motility, and to provide a mechanistic basis for these phenomena. Methods The identification of the SMAD-interacting protein 1 (SIP1) mRNA as putative miR-145 target was investigated using a 3’ untranslated region (3’UTR) luciferase assay and Western blotting, respectively. The functional effects of exogenous miR-145 expression, miR-145 suppression or siRNA-mediated SIP1 expression down-regulation in cervical cancer-derived C33A and SiHa cells were analysed using Western blotting, BrdU incorporation (proliferation), transwell migration and invasion assays. In addition, the expression levels of miR-145 and SIP1 were determined in primary human cervical cancer and non-cancer tissue samples using qRT-PCR. Results We found that miR-145 binds to the wild-type 3’UTR of SIP1, but not to its mutant counterpart, and that, through this binding, miR-145 can effectively down-regulate SIP1 expression. In addition, we found that exogenous miR-145 expression or siRNA-mediated down-regulation of SIP1 expression attenuates the proliferation, migration and invasion of C33A and SiHa cells and alters the expression of the EMT-associated markers CDH1, VIM and SNAI1, whereas inhibition of endogenous miR-145 expression elicited the opposite effects. The expression of miR-145 in cervical cancer tissue samples was found to be low, while that of SIP1 was found to be high compared to non-cancerous cervical tissues. An inverse expression correlation between the two was substantiated through the anlaysis of data deposited in the TCGA database. Conclusion Our data indicate that low miR-145 expression levels in conjunction with elevated SIP1 expression levels may contribute to cervical cancer development. MiR-145-mediated regulation of SIP1 provides a novel mechanistic basis for its tumour suppressive mode of action in human cervical cancer cells.Keywords
Funding Information
- Council of Scientific and Industrial Research, India (09/860(0076)/2008)
- Indian Institute of Technology Madras (ERP1314003RESFDKAR)
- Department of Biotechnology, Ministry of Science and Technology, India (BT/PR2672/AGR/36/702/2011)
This publication has 58 references indexed in Scilit:
- Lamin A/C deficiency is an independent risk factor for cervical cancerCellular Oncology, 2015
- MicroRNA-101 regulates the viability and invasion of cervical cancer cells.2015
- PI3K/AKT pathway-mediated regulation of p27Kip1 is associated with cell cycle arrest and apoptosis in cervical cancerCellular Oncology, 2015
- Clinical Significance of SIP1 and E-cadherin in Patients with Esophageal Squamous Cell CarcinomaAnnals of Surgical Oncology, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1British Journal of Cancer, 2014
- MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical CancerInternational Journal of Molecular Sciences, 2012
- Glucocorticoid regulation of a novel HPV–E6–p53– miR‐145 pathway modulates invasion and therapy resistance of cervical cancer cellsThe Journal of Pathology, 2012
- miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasionBiochemical and Biophysical Research Communications, 2010
- Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell GrowthPLOS ONE, 2008